Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Engerix-B Kinder challenge dose in adolescents
NCT02798952Phase 4Completed
- Sponsor
- GSK
- Start
- Aug 2016
- Primary completion
- Jul 2017
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Started Aug 2016; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02798952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02798952.